Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

Related Articles by Review for PubMed (Select 22294554)

1.

Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response.

Katz L, Gisbert JP, Manoogian B, Lin K, Steenholdt C, Mantzaris GJ, Atreja A, Ron Y, Swaminath A, Shah S, Hart A, Lakatos PL, Ellul P, Israeli E, Svendsen MN, van der Woude CJ, Katsanos KH, Yun L, Tsianos EV, Nathan T, Abreu M, Dotan I, Lashner B, Brynskov J, Terdiman JP, Higgins PD, Chaparro M, Ben-Horin S.

Inflamm Bowel Dis. 2012 Nov;18(11):2026-33. doi: 10.1002/ibd.22902. Epub 2012 Jan 31.

PMID:
22294554
2.

Infliximab use in luminal Crohn's disease.

Richter JA, Bickston SJ.

Gastroenterol Clin North Am. 2006 Dec;35(4):775-93. Review.

PMID:
17129813
3.

Review article: efficacy of infliximab in Crohn's disease--induction and maintenance of remission.

Rutgeerts PJ.

Aliment Pharmacol Ther. 1999 Sep;13 Suppl 4:9-15; discussion 38. Review.

4.

Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.

Keating GM, Perry CM.

BioDrugs. 2002;16(2):111-48. Review.

PMID:
11985485
5.

Loss of response and requirement of infliximab dose intensification in Crohn's disease: a review.

Gisbert JP, Panés J.

Am J Gastroenterol. 2009 Mar;104(3):760-7. doi: 10.1038/ajg.2008.88. Epub 2009 Jan 27. Review.

PMID:
19174781
6.

Infliximab in the treatment of Crohn's disease: a user's guide for clinicians.

Sandborn WJ, Hanauer SB.

Am J Gastroenterol. 2002 Dec;97(12):2962-72. Review.

PMID:
12492177
7.

Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.

Magro F, Portela F.

BioDrugs. 2010 Dec 14;24 Suppl 1:3-14. doi: 10.2165/11586290-000000000-00000. Review.

PMID:
21175228
8.

Effect of infliximab induction therapy on secondary systemic amyloidosis associated with Crohn's disease: case report and review of the literature.

Pukitis A, Zake T, Groma V, Ostrovskis E, Skuja S, Pokrotnieks J.

J Gastrointestin Liver Dis. 2013 Sep;22(3):333-6. Review.

9.

Mechanism and therapeutic strategy of secondary failure to anti-tumor necrosis factor-α monoclonal antibody treatment for Crohn's disease.

Matsuoka K, Kanai T.

Digestion. 2013;88(1):17-9. doi: 10.1159/000351386. Epub 2013 Jun 20. Review.

PMID:
23797247
10.

Anti-tumor necrosis factor and postoperative complications in Crohn's disease: systematic review and meta-analysis.

Kopylov U, Ben-Horin S, Zmora O, Eliakim R, Katz LH.

Inflamm Bowel Dis. 2012 Dec;18(12):2404-13. doi: 10.1002/ibd.22954. Epub 2012 Mar 29. Review.

PMID:
22467533
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk